- A Registry Study to Characterise Genetic and Pathway Biomarkers in Noonan Syndrome and Other RASopathy Patients – for more information click here.
Dr. Bronwyn Kerr
Genetic Medicine, St Mary’s Hospital
Manchester M13 9WL
(0161) 276 3742
- CASPER – The Cognitive and Social Profiling: Exploring Rasopathies (CASPER) study is a research study into a group of conditions called the RAS-MAPK pathway disorders. Go to http://www.bbmh.manchester.ac.uk/casper/AboutCASPER/ for a description.
If you would like to speak to the team at the University of Manchester for more information about the research, please contact:
If you would like to speak to the team at the Manchester Centre for Genomic Medicine, please contact;
tel: +44(0)161 701 5105
Lauren Weiss, PhD
University of California, San Francisco
Study of brain and cognitive development in boys and girls with Noonan syndrome
The project is a pilot study looking at Noonan Syndrome in children (ages 4-11). We are hoping to recruit ten families of children with a confirmed PTPN11 mutation to participate in a two-day visit to Stanford University, which will include neuropsychological testing and an MRI. Families who choose to participate will have travel arrangements covered by the study, and will receive a summary of the testing results for participating and a small monetary honorarium for participating.
Click HERE for the flyer for families interested in participating.
Hypertrophic Cardiomyopathy Study for Individuals with Noonan Syndrome with Multiple Lentigines / LEOPARD syndrome – for more information, click here.
Jane Messere, RN, Research Nurse
Children’s Hospital, Boston
Social-Emotional Development in Children with Noonan Syndrome
Parents of children and adolescents with Noonan syndrome between the ages of 8 and 16 are invited to participate in a new research study!
The purpose of the study is to characterize social development in individuals with Noonan syndrome and related disorders, and to understand how emotional and behavioral development can impact interpersonal relationships. Children with Noonan syndrome and their unaffected siblings are eligible to participate.
Study participants will be asked to complete a set of questionnaires that inquire about their family background, their child’s social development, and their child’s emotions and behavior. Forms will be completed by both parents and children. Families will also be asked to sign a release of information form so that the researchers can request records to confirm the child’s diagnosis of Noonan syndrome as well as genetic testing related to that diagnosis.
Completing the study questionnaires and forms will take approximately one hour of your time.
Please contact us for more information! The study is being conducted by Dr. Rene Pierpont, Dr. Rebekah Hudock, Dr. Peg Semrud-Clikeman and Dr. Christopher Moertel at the University of Minnesota.
For a flyer, click here.
Dr. Rene Pierpont
University of Minnesota Medical Center
St. Louis – Washington University
The Neurofibromatosis Type 1 Patient Registry (NPR1) is currently recruiting both adults and children with NF1 for a childhood brain tumor study. The goal of this study is to identify differences in medical, social, demographic, and birth characteristics of children who develop childhood brain tumors compared to those who do not develop these tumors. We are looking for individuals with NF1 who either (1) HAVE previously been diagnosed with a brain tumor younger than age 18 years or (2) HAVE NEVER had a brain tumor. For more information click here: https://nf1registry.
Completing the online questionnaire/registration will take approximately 30 minutes of your time.
A Registry Study to Characterize Genetic and Pathway Biomarkers in Noonan Syndrome and Other RASopathy patients – for more information, click here.
Meghan Mac Neal, MS, CGC, MPH
Icahn School of Medicine at Mount Sinai
Children’s Hospital, Philadelphia (CHOP)
A sleep research study to help develop a new pediatric sleep health survey to better understand how sleep health relates to RASopathies.
For parents of individuals with a RASopathy to complete a 10-15 minute online survey. Affected children between the ages of 8 and 17 may be able to participate in the study by answering the survey, as well. Anyone who understands English is eligible to participate (it is not limited to the United States).
Link to the consent and survey: https://redcap.chop.edu/
If you are a researcher who is conducting a clinical trial, please contact us.